Development and validation of an electronic medical record-based disease activity index for Behçet's disease

Clinical and Experimental Rheumatology

Volumn 32, Issue , 2014, Pages S40-S44

  Kim, Do Young ^a   Choi, Min Ju ^a   Kim, Ha Yan ^b   Cho, Suhyun ^a   Cho, Sung Bin ^a   Bang, Dongsik ^a  

^a Cutaneous Biology Research Institute   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Beh et's disease; Electronic health records; Scoring methods; Severity of illness index

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BEHCET DISEASE; BEHCET DISEASE CURRENT ACTIVITY FORM; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; ELECTRONIC MEDICAL RECORD; ELECTRONIC MEDICAL RECORD BASED DISEASE ACTIVITY INDEX; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; VALIDATION PROCESS; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; FACTUAL DATABASE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; OBSERVER VARIATION; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BEHCET SYNDROME; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84907540871     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. JAMES DG: Behçet's syndrome. N Engl J Med 1979; 301: 431-2.
2. HATEMI G, SEYAHI E, FRESKO I, HAMURYUDAN V: Behçet's syndrome: a critical digest of the recent literature. Clin Exp Rheumatol 2012; 30 (Suppl. 72): S80-9.
3. BHAKTA BB, BRENNAN P, JAMES TE, CHAMBERLAIN MA, NOBLE BA, SILMAN AJ: Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 1999; 38: 728-33.
4. HAMURYUDAN V, FRESKO I, DIRESKENELI H et al.: Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome. Rheumatology (Oxford) 1999; 38: 734-6.
5. LAWTON G, CHAMBERLAIN MA, BHAKTA BB, TENNANT A: The Behçet's disease activity index. Adv Exp Med Biol 2003; 528: 149-51.
6. LEE ES, KIM HS, BANG D et al.: Development of clinical activity form for Korean patients with Behçet's disease. Adv Exp Med Biol 2003; 528: 153-6.
7. LAWTON G, BHAKTA BB, CHAMBERLAIN MA, TENNANT A: The Behçet's disease activity index. Rheumatology (Oxford) 2004; 43: 73-8.
8. NEVES FS, MORAES JC, KOWALSKI SC, GOLDENSTEIN-SCHAINBERG C, LAGE LV, GONçALVES CR: Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 2007; 26: 1263-7.
9. YI SW, KIM JH, LIM KY, BANG D, LEE S, LEE ES: The Behçet's Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J 2008; 49: 698-704.
10. MUMCU G, SUR H, INANC N et al.: A composite index for determining the impact of oral ulcer activity in Behçet's disease and recurrent aphthous stomatitis. J Oral Pathol Med 2009; 38: 785-91.
11. SHAHRAM F, KHABBAZI A, NADJI A, ZIAIE N, BANIHASHEMI AT, DAVATCHI F: Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease. Mod Rheumato 2009; 19: 536-41.
12. CHAMBERLAIN MA, BHAKTA BB, TENNANT A, EYRES S: Behçet's disease: diagnosis and assessment of disease activity. In: BANG D, LEE ES, LEE S, eds. Behçet's disease. Seoul: Design Mecca, 2000; 105-9.
13. YAZICI H, TüZüN Y, PAZARLI H et al.: Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984; 43: 783-9.
14. MUMCU G, YAZICI Y, CHAMBERLAIN MA: Disease assessment in Behçet's disease. In: YAZICI Y, YAZICI Y, eds. Behçet's syndrome. New York: Springer, 2010: 299-315.
15. SIMSEK I, MERIC C, ERDEM H, PAY S, KILIC S, DINC A: Accuracy of recall of the items included in disease activity forms of Behçet's disease: comparison of retrospective questionnaires with a daily telephone interview. Clin Rheumatol 2008; 27: 1255-60.
16. MAYO NE, POISSANT L, AHMED S et al.: Incorporating the International Classification of Functioning, Disability, and Health (ICF) into an electronic health record to create indicators of function: proof of concept using the SF-12. J Am Med Inform Assoc 2004; 11: 514-22.
17. INTERNATIIONAL STUDY GROUP FOR BEHçET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
18. LANDIS JR, KOCH GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
19. KATSANTONIS J, ADLER Y, ORFANOS CE, ZOUBOULIS CC: Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 2000; 201: 37-9.
20. MüFTüOĞLU AU, YAZICI H, YURDAKUL S et al.: Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986; 25: 235-9.
21. AYDINTUĞ AO, TOKGöZ G, OZORAN K, DüZGüN N, GüRLER A, TUTKAK H: Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease. Rheumatol Int 1995; 15: 75-8.
22. ERTURAN I, BASAK PY, OZTURK O, CEYHAN AM, AKKAYA VB: Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behçet's disease? J Eur Acad Dermatol Venereol 2009; 23: 1414-8.
23. KATO Y, YAMAMOTO T: Serum levels of GRO-alpha are elevated in association with disease activity in patients with Behçet's disease. Int J Dermatol 2012; 51: 286-9.
24. LEE YJ, KANG SW, SONG JK et al.: Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Clin Exp Rheumatol 2007; 25: S41-5.
25. ÖZDEN MG, CAYCI YT, TEKIN H et al.: Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up. J Eur Acad Dermatol Venereol 2011; 25: 1168-73.
26. EMBI PJ, PAYNE PR: Clinical research informatics: challenges, opportunities and definition for an emerging domain. J Am Med Inform Assoc 2009; 16: 316-27.
27. PROKOSCH HU, GANSLANDT T: Perspectives for medical informatics. Reusing the electronic medical record for clinical research. Methods Inf Med 2009; 48: 38-44.
28. DAVATCHI F, AKBARAN M, SHAHRAM F et al.: Iran Behçet's disease dynamic activity index. Hung Rheumatol 1991; 32 (Suppl.): FP10-100, 134.